Clinical Trial Update: ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA [Phase 4]

View source ↗

Summary

Phase 4 trial update characterizing remission status in ulcerative colitis patients treated with 5-ASA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• 5-ASA (5-aminosalicylic acid)

Snippet

Sponsor: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED